- APHRS: New data confirm robust long-term durability and highly efficient procedure performed without fluoroscopy
- Successful launch in Japan follows recent reimbursement approval
- Approvals across APAC including China and Australia broaden reach for patients
Results were presented as a late breaking clinical trial at the Asia Pacific Heart Rhythm Society (APHRS) meeting in Sydney, Australia.
Register to read this story and more for free.
Signing up for an account helps us improve your browsing experience.
ContinueOR
See our subscription options.
Already have an account? Log in here